Allergan Aesthetics

Houston, United States Founded: 1993 • Age: 33 yrs Listed Acquired By Allergan Aesthetics
Allergan Aesthetics is focused on developing aesthetic medicine solutions.

About Allergan Aesthetics

Allergan Aesthetics is a Healthcare company based in Houston (United States) founded in 1993, and was acquired by Allergan Aesthetics in May 2021. Allergan Aesthetics is focused on developing aesthetic medicine solutions. It operates on a Direct-to-Consumer (D2C) and Professional Services model. Allergan Aesthetics has raised $14.3 million across 7 funding rounds from investors including Remeditex and Allergan Aesthetics. The company has 23 employees. Allergan Aesthetics offers products and services including BOTOX® Cosmetic, JUVÉDERM® Collection, CoolSculpting®, Natrelle® Breast Implants, and LATISSE®. Its focus areas include Medical Devices and Aesthetic Medicine. Its legal entity is Allergan Aesthetics, an AbbVie Company. Its competitors include Cytrellis, Procell Therapies and Altair Instruments; 1 of its 3 listed competitors has raised funding.

Company details

Allergan Aesthetics, an AbbVie company, is engaged in the development and distribution of aesthetic medicine products and technologies. Solutions are provided in facial aesthetics, body contouring, and regenerative medicine. The portfolio includes well-known brands such as BOTOX Cosmetic, JUVÉDERM fillers, CoolSculpting, and Natrelle breast implants. Operations are centered on enhancing patient confidence through scientifically backed treatments. The company serves both individual consumers and healthcare providers across various sectors of aesthetic care.

  • Headquarters Houston, United States
  • Employees 23
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website soliton.com
  • Social LinkedIn X Facebook Instagram
  • Acquired by Allergan Aesthetics (May 2021)
  • Legal Name Allergan Aesthetics, An Abbvie Company
Operational Areas
Key Metrics
  • Total Equity Funding
    $14.3M (USD)

    in 7 rounds

  • Latest Funding Round
    $6.25M (USD), Post-IPO

    Oct 2019

  • Investors
    Remeditex

    & 1 more

  • Employee Count
    23
  • Acquired by

Products & Services of Allergan Aesthetics

Allergan Aesthetics offers a comprehensive portfolio of products and services, including BOTOX® Cosmetic, JUVÉDERM® Collection, CoolSculpting®, Natrelle® Breast Implants, and LATISSE®.

BOTOX® Cosmetic
Facial Aesthetics

Used to reduce moderate to severe facial lines.

JUVÉDERM® Collection
Facial Aesthetics

Injectable gels for facial wrinkles and volume loss.

CoolSculpting®
Body Contouring

Non-invasive treatment for reducing visible fat bulges.

Natrelle® Breast Implants
Regenerative Medicine

Implants used for breast augmentation and reconstruction.

LATISSE®
Facial Aesthetics

Treatment to grow eyelashes for inadequate lashes.

Funding Insights of Allergan Aesthetics

Allergan Aesthetics has successfully raised a total of $14.3M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $6.25 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $14.3M
  • Total Rounds 7
  • Last Round Post-IPO — $6.25M
  • First Round $1M

    (Apr 2012)

  • Investors Count 1

All 7 funding rounds of Allergan Aesthetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2019$6.25MPost-IPO––
Jun 2019$9.5MPost-IPO––
Apr 2018$500,000Debt – Conventional––
–
Jul 2017$4.3MSeries B––
–
Jul 2016$1MSeries B––
–
Nov 2015$9MSeries B––
–
Apr 2012$1MUnspecified––
–
Valuation history

2 investors in total: 2 institutional.

Investors in Allergan Aesthetics

Allergan Aesthetics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Remeditex and Allergan Aesthetics.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
remeditex.com
Medical aesthetics products and treatments are provided.
allerganaesthetics.com
Premium access

Investor details for Allergan Aesthetics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Allergan Aesthetics

6 people are tracked at Allergan Aesthetics (2 in leadership, 4 in board & advisors); the tracked headcount is 23.

NameRoleGroup
Joe Tanner
Chief Operating OfficerLeadership
Christopher Capelli
Co-Founder, CEO and CSOLeadership
Brad Hauser
Independent DirectorBoard & advisors
Danika Harrison
Independent DirectorBoard & advisors
Jonathan Foster
Independent DirectorBoard & advisors
Walter V. Klemp
Co-Founder and Executive ChairmanBoard & advisors
Premium access

Complete people profiles for Allergan Aesthetics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Allergan Aesthetics

5 dated milestones of Allergan Aesthetics across 28 years, from founding to its latest funding, stage changes and deals.

  1. Founded Allergan Aesthetics is founded.
  2. Funding First funding round of $1.0M.
  3. IPO Lists on the stock exchange (IPO).
  4. Funding Latest funding round, Post-IPO, of $6.2M.
  5. Exit Acquired by Allergan Aesthetics.

Competitors of Allergan Aesthetics

Allergan Aesthetics has 3 listed competitors in our database, 1 of them funded. They include Cytrellis, Procell Therapies and Altair Instruments.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cytrellis.com2012Boston, United States$111.22M59
Developer of aesthetic devices for scar reduction and skin tightening
procelltherapies.com2013Austin, United States5
Microneedling and dermabrasion systems are developed for aesthetic procedures.
altairinstruments.com1981Ventura, United States
Offers microdermabrasion machines, wands, and serums for professional skin treatments worldwide.
Premium access

Detailed competitors of Allergan Aesthetics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Allergan Aesthetics

Websites that share an audience with Allergan Aesthetics (soliton.com).

Similar websites

Websites whose visitors overlap most with Allergan Aesthetics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
microapl.co.uk
microapl.co.uk
100%
–
cosy.com
cosy.com
93%
–
dyalog.com
93%
#1,684,104View details
kx.com
93%
114K#337,105View details
jsoftware.com
93%
#1,357,316View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 16 similar websites and full traffic analytics for Allergan Aesthetics

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 16 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Dermatology

3 companies that operate in the same segment as Allergan Aesthetics (Dermatology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
2002Newark, New Jersey, United StatesUSD 154.56 MUSD 234.04 M597
Diagnostic tests for cancer prognosis are provided.
2008Friendswood, Texas, United StatesUSD 61.97 MUSD 344.23 M761
Adhesive patch biopsies for skin cancer detection are provided.
1996San Diego, California, United StatesUSD 24.37 MUSD 15.3 M259
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Allergan Aesthetics

Premium access

Complete news archive for Allergan Aesthetics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Allergan Aesthetics

Allergan Aesthetics was founded in 1993 and raised its 1st funding round 19 years after it was founded.

Allergan Aesthetics is headquartered in Houston, United States. It is registered at Houston, Texas, United States.

Allergan Aesthetics is a funded company, having raised a total of $14.3M across 7 funding rounds to date. The company's 1st funding round was a Unspecified of $1M, raised on Apr 2012.

Allergan Aesthetics has 23 employees.

Allergan Aesthetics, an AbbVie company, is engaged in the development and distribution of aesthetic medicine products and technologies. Solutions are provided in facial aesthetics, body contouring, and regenerative medicine. The portfolio includes well-known brands such as BOTOX Cosmetic, JUVÉDERM fillers, CoolSculpting, and Natrelle breast implants. Operations are centered on enhancing patient confidence through scientifically backed treatments. The company serves both individual consumers and healthcare providers across various sectors of aesthetic care.

Allergan Aesthetics's top competitors include Cytrellis, Procell Therapies and Altair Instruments.

Allergan Aesthetics offers BOTOX® Cosmetic, JUVÉDERM® Collection, CoolSculpting®, Natrelle® Breast Implants, and LATISSE®.

Allergan Aesthetics has 2 investors. Key investors include Remeditex, and Allergan Aesthetics.

Allergan Aesthetics operates through Allergan Aesthetics, An Abbvie Company.

Yes. Allergan Aesthetics was acquired by Allergan Aesthetics in May 2021.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available